VIVO Financial Facts
General and administrative: 7.98MOPERATING INCOME: 8.9M
See Full Income Statement
Other intangible assets, net: -39.6M
Less: accumulated depreciation and amortization: 49.22M
See Full Balance Sheet
Meridian Bioscience Inc. (VIVO) Earnings
|
Expand Research on VIVO
| Next EPS Date | 12/3/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +39.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9/10/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/8/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/7/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/3/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/31/26 |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 6/3/26 |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 1/26/23 | Q123 | N/A | $0.20 | N/A | N/A | $72.3M | N/A | N/A | N/A | ||
| 11/14/22 | Q422 | N/A | $0.12 | N/A | N/A | $63M | = | N/A | N/A |



